RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
On Thursday, Ascendiant analyst Edward Woo raised the price target on RenovoRx Inc. (NASDAQ:RNXT) to $11.50 from $11, while maintaining a Buy rating on the shares.
Renovorx Inc. (RNXT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 3,467,275 | $4,563,835 | 2.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.40 | 21,000 | $29,400.00 | 734,460 | 2025-06-05 | Filing | |
| $0.90 | 15,000 | $13,500.00 | 1,113,460 | 2025-04-15 | Filing | |
| $0.91 | 7,500 | $6,821.25 | 320,040 | 2025-04-15 | Filing | |
| $0.80 | 20,000 | $16,000.00 | 1,098,460 | 2025-04-11 | Filing | |
| $0.79 | 6,500 | $5,135.00 | 12,595 | 2025-04-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 92,356 | $117,292 | 0% | |
| 2. | 13,279 | $17,462 | 0% | |
| 3. | 10,656 | $14,013 | 0% |
News See All
RenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the RenovoRx Q1 2025 Financial and Operational Highlights Conference Call. All participants will be in a listen-only mode.